tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Income Statement

Compare
360 Followers

Phathom Pharmaceuticals Income Statement

Last quarter (Q3 2024), Phathom Pharmaceuticals's total revenue was $16.35M, an increase of Infinity% from the same quarter last year. In Q3, Phathom Pharmaceuticals's net income was $-85.58M. See Phathom Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 682.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 515.00K$ -620.00K$ -521.00K$ -300.00K$ -8.00K
Operating Expenses
$ 167.83M$ 172.44M$ 135.08M$ 125.67M$ 106.22M
Depreciation and Amortization
$ 575.00K$ 620.00K$ 521.00K$ 300.00K$ 8.00K
EBITDA
$ -159.05M$ -171.82M$ -134.56M$ -124.19M$ -250.95M
Operating Income
$ -167.31M$ -172.44M$ -135.08M$ -125.67M$ -106.22M
Other Income/Expenses
$ -34.28M$ -25.28M$ -8.80M$ -3.40M$ -148.92M
Pretax Income
$ -201.59M$ -197.72M$ -143.88M$ -129.07M$ -255.13M
Net Income
$ -201.59M$ -223.01M$ -148.09M$ -133.32M$ -209.74M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.93$ -5.70$ -4.00$ -4.01$ -8.48
Diluted EPS
$ -3.93$ -5.70$ -4.00$ -4.01$ -8.48
Weighted Average Shares Outstanding
51.29M 39.12M 37.00M 33.23M 24.73M
Weighted Average Shares Outstanding (Diluted)
51.29M 39.12M 37.00M 33.23M 24.73M
Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis